ViaDerma in The Press

ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
LOS ANGELES, July 06, 2023 (Yahoo! Finance) – ViaDerma, Inc. (OTC Pink: VDRM) is very […]

ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
The Company unveils brand name for its planned minoxidil hair regrowth productLOS ANGELES, March 16, […]

ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
LOS ANGELES, March 08, 2023 (Benzinga) – ViaDerma, Inc. (OTC: VDRM) is pleased to announce […]

ViaDerma Provides an Update on Current & Future Business Activities
The Company has expanded its current wound care licensing agreement to 11 states and expects […]

ViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth Online
ViaDerma, Inc. (OTC Pink: VDRM) is extremely pleased to announce that they have retained the […]

ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products
LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) ViaDerma, Inc., (OTC Pink: VDRM) announces the successful […]

ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) — ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces […]

ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) — ViaDerma, Inc., (OTC Pink: VDRM) is pleased […]

ViaDerma, Inc. Files Amended Financial Statements
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) ViaDerma, Inc., (OTC Pink: VDRM) published a Quarterly […]
ViaDerma, Inc. Provides Updates On Current Business Activities
LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) — ViaDerma, Inc., (“Company”) (OTCPink:VDRM), is pleased to […]
ViaDerma, Inc. Provides an Update on its Current Marketing Efforts
LOS ANGELES, Aug. 27, 2020 (GLOBE NEWSWIRE) ViaDerma, Inc., (OTC Pink:VDRM), is pleased to provide […]
ViaDerma Targets Online Sales, Wound Care Centers and Distribution Companies for its Viabecline Product Launch, the First Viabecline Orders Set for Q2-2017, also Onychomycosis Clinical Studies Show Significant Results
LOS ANGELES, CA (Yahoo! Finance – February 03, 2017) – ViaDerma, Inc. (OTC PINK: VDRM), a […]
TetraStem Antibiotic Continues to Demonstrate Treatment Success Leading Management to Explore Partnerships With Big Pharmaceutical Companies
LOS ANGELES, Dec. 9, 2014 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to […]